Abstract 63P
Background
Colorectal cancer is one of the most common cancers in our country. Different clinicopathological features and outcome have been demonstrated between right and left CRC. In our study, we aim to characterize tumor sidedness, clinical profile and histological features of colorectal cancer to improve oncological care.
Methods
The data was retrospectively taken from Medical Oncology OPD Registry, YGH, over one year period from January, 2020 to December, 2020. Summary statistics were used to describe results.
Results
Total 225 (63 right side and 162 left side) patients were included in this study. Right sided tumor included from caecum to splenic flexure. Left sided one represented the remaining large bowel including rectum. The sites observed were caecum (6.6%), ascending colon (9.3%), hepatic flexure (6.6%), transverse colon (3.5%), splenic flexure (1.7%), descending colon (5.7%), sigmoid colon (7.5%), recto-sigmoid (12%) and rectum (46%) respectively. Mean age was 52 years, the youngest was 14 years and the oldest was 89 years. Forty percents of patients were <50 years of age. In right side, male patients (52%) were more than female patients (48%). In left side, slight female preponderance over male (51% Vs 49%) was seen. Presentation with intestinal obstruction or perforation was more commonly seen in right side (38%) than left side (22%). The most common histological subtype in both sides was moderately differentiated adenocarcinoma. Special subtype (mucinous and signet ring cell type) was more commonly seen in right side (24%) than left side (10.5%). More than 80% of patients came with advanced stage (stage III and IV) in both sides. The most common site of metastasis from both sides was peritoneum and liver.
Conclusions
In this study, there were more patients with left-sided CRC than right-sided. And like other countries, the burden of disease in younger patients is quite concerning. As most patients were diagnosed at advanced stage, necessary interventions for CRC awareness should be promoted. This study also highlights that clinicopathological differences exist between right and left colorectal cancer, possibly indicating prognostic significance that might improve the oncological care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
89P - Radiotherapy followed by camrelizumab for unresectable biliary tract cancer: A phase II clinical trial
Presenter: Zhenwei Peng
Session: Poster viewing 02
90P - Feasibility of using tumor-informed circulating tumor DNA (ctDNA)-based testing for patients with anal squamous cell carcinoma
Presenter: Georges Azzi
Session: Poster viewing 02
92P - Safety of liver resection following atezolizumab plus bevacizumab treatment in hepatocellular carcinoma (HCC) patients with macrovascular invasion: A pre-specified analysis of the TALENTop study
Presenter: Huichuan Sun
Session: Poster viewing 02
93P - Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
Presenter: Takuji Okusaka
Session: Poster viewing 02
94P - The treatment burden of neoadjuvant carboplatin/paclitaxel versus 5-fluorouracil/cisplatin in combination with radiotherapy for patients with esophageal cancer
Presenter: Chun-Ling Chi
Session: Poster viewing 02
95P - Additional survival follow-up of TACTICS-L: Transcatheter arterial chemoembolization therapy (TACE) in combination strategy with lenvatinib in (LEN) patients with unresectable hepatocellular carcinoma in Japan
Presenter: Yoshitaka Inaba
Session: Poster viewing 02
96P - Preoperative chemotherapy flot vs dox in patients of locally advanced gastric adenocarcinoma
Presenter: POORNIMA DEVI UTHAYAKUMAR
Session: Poster viewing 02
97P - BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma
Presenter: Nai-Jung Chiang
Session: Poster viewing 02